Literature DB >> 26460340

Endocrinology research-reflecting on the past decade and looking to the next.

Kevan C Herold1, Joseph A Majzoub2, Shlomo Melmed3, Merri Pendergrass4, Martin Schlumberger5.   

Abstract

The inaugural issue of this journal, published in November 2005, included articles on thyroid cancer, type 2 diabetes mellitus, the metabolic syndrome, pituitary adenomas and obesity. 10 years later, we are still publishing articles on these topics (and many others). Although a great deal of progress has been made in our understanding of the pathogenesis, diagnosis and treatment of diseases of the endocrine system over the past 10 years, many challenges still remain. For this Viewpoint, we have asked five of our Advisory Board Members to comment on the progress and challenges from the past 10 years. They were also asked to offer their thoughts on where money should be spent going forward, and their predictions for what advances might be achieved in the next 10 years.

Entities:  

Mesh:

Year:  2015        PMID: 26460340     DOI: 10.1038/nrendo.2015.164

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  63 in total

1.  Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry.

Authors:  Kellee M Miller; Nicole C Foster; Roy W Beck; Richard M Bergenstal; Stephanie N DuBose; Linda A DiMeglio; David M Maahs; William V Tamborlane
Journal:  Diabetes Care       Date:  2015-06       Impact factor: 19.112

Review 2.  Thinking bedside at the bench: the NOD mouse model of T1DM.

Authors:  James C Reed; Kevan C Herold
Journal:  Nat Rev Endocrinol       Date:  2015-01-27       Impact factor: 43.330

Review 3.  New and future immunomodulatory therapy in type 1 diabetes.

Authors:  James E Tooley; Frank Waldron-Lynch; Kevan C Herold
Journal:  Trends Mol Med       Date:  2012-02-17       Impact factor: 11.951

4.  Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2.

Authors:  Louise A Metherell; J Paul Chapple; Sadani Cooray; Alessia David; Christian Becker; Franz Rüschendorf; Danielle Naville; Martine Begeot; Bernard Khoo; Peter Nürnberg; Angela Huebner; Michael E Cheetham; Adrian J L Clark
Journal:  Nat Genet       Date:  2005-01-16       Impact factor: 38.330

5.  Integrated genomic characterization of papillary thyroid carcinoma.

Authors: 
Journal:  Cell       Date:  2014-10-23       Impact factor: 41.582

6.  Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.

Authors:  Anna L Gloyn; Ewan R Pearson; Jennifer F Antcliff; Peter Proks; G Jan Bruining; Annabelle S Slingerland; Neville Howard; Shubha Srinivasan; José M C L Silva; Janne Molnes; Emma L Edghill; Timothy M Frayling; I Karen Temple; Deborah Mackay; Julian P H Shield; Zdenek Sumnik; Adrian van Rhijn; Jerry K H Wales; Penelope Clark; Shaun Gorman; Javier Aisenberg; Sian Ellard; Pål R Njølstad; Frances M Ashcroft; Andrew T Hattersley
Journal:  N Engl J Med       Date:  2004-04-29       Impact factor: 91.245

7.  Central precocious puberty caused by mutations in the imprinted gene MKRN3.

Authors:  Ana Paula Abreu; Andrew Dauber; Delanie B Macedo; Sekoni D Noel; Vinicius N Brito; John C Gill; Priscilla Cukier; Iain R Thompson; Victor M Navarro; Priscila C Gagliardi; Tânia Rodrigues; Cristiane Kochi; Carlos Alberto Longui; Dominique Beckers; Francis de Zegher; Luciana R Montenegro; Berenice B Mendonca; Rona S Carroll; Joel N Hirschhorn; Ana Claudia Latronico; Ursula B Kaiser
Journal:  N Engl J Med       Date:  2013-06-05       Impact factor: 91.245

8.  Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.

Authors:  Andrey P Babenko; Michel Polak; Hélène Cavé; Kanetee Busiah; Paul Czernichow; Raphael Scharfmann; Joseph Bryan; Lydia Aguilar-Bryan; Martine Vaxillaire; Philippe Froguel
Journal:  N Engl J Med       Date:  2006-08-03       Impact factor: 91.245

9.  Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum.

Authors:  Itamar Raz; Matthew C Riddle; Julio Rosenstock; John B Buse; Silvio E Inzucchi; Philip D Home; Stefano Del Prato; Ele Ferrannini; Juliana C N Chan; Lawrence A Leiter; Derek Leroith; Ralph Defronzo; William T Cefalu
Journal:  Diabetes Care       Date:  2013-06       Impact factor: 19.112

10.  Mobilized adult pituitary stem cells contribute to endocrine regeneration in response to physiological demand.

Authors:  Karine Rizzoti; Haruhiko Akiyama; Robin Lovell-Badge
Journal:  Cell Stem Cell       Date:  2013-10-03       Impact factor: 24.633

View more
  2 in total

Review 1.  Pituitary Medicine From Discovery to Patient-Focused Outcomes.

Authors:  Shlomo Melmed
Journal:  J Clin Endocrinol Metab       Date:  2016-02-23       Impact factor: 5.958

2.  Platelet-Derived Mitochondria Display Embryonic Stem Cell Markers and Improve Pancreatic Islet β-cell Function in Humans.

Authors:  Yong Zhao; Zhaoshun Jiang; Elias Delgado; Heng Li; Huimin Zhou; Wei Hu; Marcos Perez-Basterrechea; Anna Janostakova; Qidong Tan; Jing Wang; Mao Mao; Zhaohui Yin; Ye Zhang; Ying Li; Quanhai Li; Jing Zhou; Yunxiang Li; Eva Martinez Revuelta; Jose Maria García-Gala; Honglan Wang; Silvia Perez-Lopez; Maria Alvarez-Viejo; Edelmiro Menendez; Thomas Moss; Edward Guindi; Jesus Otero
Journal:  Stem Cells Transl Med       Date:  2017-07-07       Impact factor: 6.940

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.